Search for: "Novartis Pharmaceuticals Corp" Results 301 - 320 of 367
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Apr 2009, 7:13 pm
Novartis Pharmaceuticals Corp. et al. 2:09-cv-01592; filed April 16, 2009 in the Eastern District of Pennsylvania Declaratory judgment of invalidity and non-infringement of U.S. [read post]
16 Apr 2009, 7:27 am
" Notably, "Eli Lilly and Co., Pfizer Inc., Novartis Pharmaceuticals Corp., Merck & Co. and Forest Pharmaceuticals Inc. were the biggest spenders. [read post]
20 Mar 2009, 2:05 am
Novartis Pharmaceuticals Corp., 283 F.3d 254, 272 n.11 (5th Cir. 2002); Williams v. [read post]
2 Feb 2009, 11:30 am
Novartis Pharmaceutical Corp., Novartis seems to have come out on top, to the disappointment of plaintiff, Frank Maldonado, thanks to an unusually harsh application of the concept of constructive notice. [read post]
2 Feb 2009, 9:51 am
This January 2008 press release from KV Pharmaceutical, the parent company of ETHEX, includes a list of the more than 60 generic drugs being recalled by ETHEX. [read post]
31 Dec 2008, 6:51 pm
Recent news reports have allowed us to add thirteen biotech/pharma companies and a trade group to the list: • The Pharmaceutical Research and Manufacturers of America (PhRMA), which has more than 30 members including Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Novartis Corp., Pfizer Inc., and Sanofi-Aventis SA, spent more than $5.4 million on third quarter lobbying (see… [read post]
5 Dec 2008, 5:31 am
By Mark Chael -- On December 2nd, Mylan, Inc. and Mylan Pharmaceuticals, Inc. announced that they had settled their dispute with Novartis Pharmaceuticals Corp., Novartis Corp., and Novartis International AG over a generic version of Novartis' Femara ® tablets.According to the press release, Femara ® tablets, which are used in the treatment of breast cancer, had U.S. sales of about $470 million for the… [read post]
2 Oct 2008, 12:36 pm
Novartis Pharmaceuticals Corp., 283 F.3d 254, 266-68 (5th Cir. 2002), where the court didn't let the plaintiff get away with arguing that there should have been a warning about "liver failure" and "death" in addition to "hepatitis. [read post]
18 Sep 2008, 10:13 am
Novartis Pharmaceuticals Corp., 2008 WL 1847077 (W.D.N.C. 2008)(denying parties' Joint Motion to Stay Proceedings without prejudice to renewal of said motion after the completion of discovery). [read post]
12 Sep 2008, 2:33 pm
: (IP finance), MARQUES international advertising portal goes live: (Class 46)   Global - Patents Using patent landscaping analytics to improve the quality of M & A decisions: a review of Cox Enterprises’ $300M purchase of Adify: (IP Asset Maximiser Blog), Universities reap royalty rewards; investors ignore IP at their peril: (IAM), Top IP-owning nations claim faster patent processing; near harmonisation deal: (Intellectual Property Watch), Bosch, Xerox and Dupont sign up… [read post]
25 Aug 2008, 4:10 am
Novartis Pharmaceuticals Corp., Benitec Australia, Ltd. v. [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP)   Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt)     Events 26 August:… [read post]
21 Aug 2008, 9:43 pm
Novartis Pharmaceuticals Corp., the court reconsidered its ruling and decided under all the circumstances there was still not an Article III case or controversy.The Federal Circuit affirmed. [read post]
9 Aug 2008, 1:50 am
: (Techdirt), Microsoft Research launches new tools for knowledge sharing: (creativecommons.org), Yet another star singer, Duffy, doesn’t mind file-sharing: (Techdirt)   Events 20 August – Bill Patry speaking on copyright – Melbourne: (Patry Copyright Blog), (LawFont.com), 21 August – Bill Patry speaking on copyright – Canberra: (Patry Copyright Blog), (LawFont.com), 22 August – Bill Patry speaking on copyright – Sydney:… [read post]
6 Aug 2008, 3:04 pm
Novartis Pharmaceuticals Corp. has prevailed in a motion to end certain failure-to-warn claims in cases in the MDL relating to its bone cancer drugs Aredia and Zometa. [read post]